Evidence map›Paper›PMID 26572152›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Identification of CTNNB1 mutations, CTNNB1 amplifications, and an Axin2 splice variant in juvenile angiofibromas.

Silke Wemmert, Vivienne Willnecker, Philipp Kulas, Stefanie Weber, Cornelia Lerner, Sabrina Berndt, Olaf Wendler, Bernhard Schick

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Neural Crest Stem Cells in Juvenile Angiofibromas.International journal of molecular sciences · 2022
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Silke WemmertDepartment of Otolaryngology, Saarland University Medical Center, 66421, Homburg/Saar, Germany. silke.wemmert@uks.eu.
Vivienne WillneckerDepartment of Otolaryngology, Saarland University Medical Center, 66421, Homburg/Saar, Germany.
Philipp KulasDepartment of Otolaryngology, Saarland University Medical Center, 66421, Homburg/Saar, Germany.
Stefanie WeberDepartment of Otolaryngology, Saarland University Medical Center, 66421, Homburg/Saar, Germany.
Cornelia LernerDepartment of Otolaryngology, Saarland University Medical Center, 66421, Homburg/Saar, Germany.
Sabrina BerndtDepartment of Otolaryngology, Saarland University Medical Center, 66421, Homburg/Saar, Germany.
Olaf WendlerExperimental Otorhinolaryngology, ENT-Hospital, Head and Neck Surgery, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, 91054, Germany.
Bernhard SchickDepartment of Otolaryngology, Saarland University Medical Center, 66421, Homburg/Saar, Germany.
Saarland University · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Juvenile angiofibromas (JAs) are benign fibro-vascular tumors occurring nearly exclusively in adolescent males. Even less is known about this rare tumor entity, alterations affecting the Wnt-pathway seem to play a pivotal role in tumor biology as activating CTNNB1 mutations have been detected. However, the knowledge of Wnt-pathway changes is still limited. Therefore, we aimed to determine in JAs further insight into Wnt/β-catenin pathway components. In our present study, genetic alterations of the Wnt-pathway members CTNNB1, APC, GSK3β, and Axin2 detected by metaphase comparative genomic hybridization (CGH) were shown to result in elevated transcript levels in the majority of JA samples compared to nasal mucosa stroma (p < 0.001, p = 0.001, p = 0.046, and p = 0.006, respectively). Additionally, amplifications of CTNNB1 were validated by fluorescence in situ hybridization (FISH) and genomic qPCR. Moreover, our mutation analysis detected already known mutations as well as, to the best of our knowledge, mutations and an interstitial deletion of CTNNB1 not described in JAs before. Additionally, a so far unknown transcribed Axin2 splice variant was found, but no further Axin2 mutations. Taken together, our current study supports the importance of aberrant Wnt-signaling as a common event in JAs, most likely by the observed genetic alterations driven by mutations, interstitial deletions but also amplifications of CTNNB1 contributing to the stabilization of β-catenin.

Indexed as

Adenomatous Polyposis Coli ProteinAdolescentAdultAngiofibromaAxin Proteinbeta CateninChildGlycogen Synthase Kinase 3 betaHumansMaleMutationProtein IsoformsWnt Signaling PathwayYoung AdultAdenomatous Polyposis Coli ProteinAPC protein, humanAXIN2 protein, humanAxin Proteinbeta CateninCTNNB1 protein, humanGlycogen Synthase Kinase 3 betaGSK3B protein, humanProtein IsoformsFISHJuvenile angiofibromaMutationsqPCRβ-Catenin

Identifiers

PMID26572152
OpenAlexW2179907648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.